ApoPharma Clinical Trial

A multicenter,randomized, double blind, placebo controlled 12 week trial of APO805K1.

Inclusion Criteria:

• Must by 18 - 65 years of age
• Moderate to severe plaque type psoriasis >10% body surface area.
• Be willing to stay overnight in the hospital twice during the study, and participate in biopsy of psoriasis lesions.

Contact: Dr. Michael Caglia, 801-213-2629